Cargando…
Do low levels of alanine aminotransferase, a baseline marker of sarcopenia and frailty, associate with worse clinical outcomes among hospitalized COVID-19 patients? A Retrospective Cohort Study
OBJECTIVES: COVID-19 geoperdize lives. Not all the risk factors for negative outcomes are known. Sarcopenia and frailty are common, negatively affecting clinical outcomes. Studies have shown that sarcopenia and frailty are associated with worse outcomes. Our objective was to examine whether low ALT...
Autores principales: | Gatt, Ehud Raz, Zilber, Eyal, Perelman, Max, Landau, Nitsan, Yakir, Maya, Glick, Noam, Negru, Liat, Segal, Gad, Itelman, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
HYLONOME PUBLICATIONS
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472039/ https://www.ncbi.nlm.nih.gov/pubmed/37663161 http://dx.doi.org/10.22540/JFSF-08-148 |
Ejemplares similares
-
Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 Patients
por: Laufer, Menachem, et al.
Publicado: (2023) -
Mortality prediction upon hospital admission – the value of clinical assessment: A retrospective, matched cohort study
por: Glick, Noam, et al.
Publicado: (2022) -
Assessing the Usability of a Novel Wearable Remote Patient Monitoring Device for the Early Detection of In-Hospital Patient Deterioration: Observational Study
por: Itelman, Edward, et al.
Publicado: (2022) -
Remote Auscultation of Heart and Lungs as an Acceptable Alternative to Legacy Measures in Quarantined COVID-19 Patients—Prospective Evaluation of 250 Examinations
por: Haskel, Or, et al.
Publicado: (2022) -
Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study
por: Itelman, Edward, et al.
Publicado: (2023)